Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

297 ARTÍCULOS , VIENDO DEL 181 AL 195

Early postoperative management of DBS in dystonia: programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting

Kupsch A, Tagliati M, Vidailhet M, Aziz T, Krack P, Moro E, Krauss JK.

Mov Disord. 2011 Jun;26 Suppl 1:S37-53. doi: 10.1002/mds.23624.

Stochastic resonance therapy in Parkinson's disease

Kaut O, Allert N, Coch C, Paus S, Grzeska A, Minnerop M, Wüllner U.

NeuroRehabilitation. 2011;28(4):353-8. doi: 10.3233/NRE-2011-0663.

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease

Yokoyama H, Kuroiwa H, Kasahara J, Araki T.

Acta Neurobiol Exp (Wars). 2011;71(2):269-80. doi: 10.55782/ane-2011-1847.

Nonmotor symptom complex of Parkinson's disease--an under-recognized entity

Mehndiratta M, Garg RK, Pandey S.

J Assoc Physicians India. 2011 May;59:302-8, 313.

Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence?

LaRoia H, Louis ED.

Neuroepidemiology. 2011;37(1):1-10. doi: 10.1159/000328866. Epub 2011 Jul 13.

Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease

Lan CC, Su TP, Chen YS, Bai YM.

Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):411.e3-5. doi: 10.1016/j.genhosppsych.2011.02.006. Epub 2011 Apr 1.

Body weight gain and deep brain stimulation

Rieu I, Derost P, Ulla M, Marques A, Debilly B, De Chazeron I, Chéreau I, Lemaire JJ, Boirie Y, Llorca PM, Durif F.

J Neurol Sci. 2011 Nov 15;310(1-2):267-70. doi: 10.1016/j.jns.2011.06.055. Epub 2011 Jul 18.

Short questionnaire for Parkinson's disease as a screening instrument

Setthawatcharawanich S, Sathirapanya P, Phabphal K, Limapichat K.

Clin Neurol Neurosurg. 2011 Dec;113(10):885-8. doi: 10.1016/j.clineuro.2011.07.001. Epub 2011 Jul 30.

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration

Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P.

Brain. 2011 Nov;134(Pt 11):3146-66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2.

Disease modification in Parkinson's disease

Henchcliffe C, Severt WL.

Drugs Aging. 2011 Aug 1;28(8):605-15. doi: 10.2165/11591320-000000000-00000.

A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease

Parkinson Study Group POETRY Investigators.

Parkinsonism Relat Disord. 2011 Dec;17(10):757-60. doi: 10.1016/j.parkreldis.2011.07.007. Epub 2011 Aug 6.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

Endoscopic third ventriculotomy improves parkinsonism following a ventriculo-peritoneal shunt in a patient with non-communicating hydrocephalus secondary to idiopathic aqueduct stenosis

Hashizume A, Watanabe H, Matsuo K, Katsuno M, Tanaka F, Nagatani T, Sobue G.

J Neurol Sci. 2011 Oct 15;309(1-2):148-50. doi: 10.1016/j.jns.2011.07.025. Epub 2011 Aug 12.

Clinical approach to nonmotor sensory fluctuations in Parkinson's disease

Bayulkem K, Lopez G.

J Neurol Sci. 2011 Nov 15;310(1-2):82-5. doi: 10.1016/j.jns.2011.07.056. Epub 2011 Aug 27.

Imaging biomarkers in Parkinson's disease

Brooks DJ, Pavese N.

Prog Neurobiol. 2011 Dec;95(4):614-28. doi: 10.1016/j.pneurobio.2011.08.009. Epub 2011 Aug 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias